Predictors of driving risk in patients with obstructive sleep apnea syndrome treated by continuous positive airway pressure: a French multicenter prospective cohort.

IF 5.6 2区 医学 Q1 Medicine
Sleep Pub Date : 2024-11-08 DOI:10.1093/sleep/zsae211
Julien Coelho, Sébastien Bailly, Sébastien Baillieul, Patricia Sagaspe, Walter T McNicholas, Jacques Taillard, Jean-Arthur Micoulaud-Franchi, Marc Sapène, Yves Grillet, Renaud Tamisier, Jean-Louis Pépin, Pierre Philip
{"title":"Predictors of driving risk in patients with obstructive sleep apnea syndrome treated by continuous positive airway pressure: a French multicenter prospective cohort.","authors":"Julien Coelho, Sébastien Bailly, Sébastien Baillieul, Patricia Sagaspe, Walter T McNicholas, Jacques Taillard, Jean-Arthur Micoulaud-Franchi, Marc Sapène, Yves Grillet, Renaud Tamisier, Jean-Louis Pépin, Pierre Philip","doi":"10.1093/sleep/zsae211","DOIUrl":null,"url":null,"abstract":"<p><strong>Study objectives: </strong>To investigate the predictors of persistent driving risk related to sleepiness in patients with obstructive sleep apnea syndrome (OSAS) treated by continuous positive airway pressure (CPAP).</p><p><strong>Methods: </strong>Longitudinal analysis of a prospective national database including 5308 patients with OSAS and an indication of CPAP. Near misses related to sleepiness, accidents related to sleepiness, and sleepiness at the wheel (SAW) were assessed before initiation and after ≥90 days of treatment. Multivariable associations with the cumulative incidence of near-misses and accidents under treatment were calculated using Cox models adjusted for age, sex, obesity, sleep duration, SAW, accidents/near-misses history, depressive symptoms, residual apnea-hypopnea index, and adherence to treatment.</p><p><strong>Results: </strong>Residual SAW under treatment was associated with an eight-fold higher incidence of near-misses related to sleepiness (hazard ratios [HR] = 8.63 [6.08-12.2]) and five-fold higher incidence of accidents related to sleepiness (HR = 5.24 [2.81-9.78]). Adherence ≤4 h/night was also a significant predictor of persistent driving risk (HR = 1.74 [1.12-2.71] for near-misses and HR = 3.20 [1.37-7.49] for accidents).</p><p><strong>Conclusions: </strong>Residual SAW and treatment adherence ≤4 h/night are easy-to-assess markers to detect persistent driving risk during the follow-up evaluations of patients under treatment. Health professionals, but also policymakers, should be aware of the crucial importance of systematically evaluating these elements during the follow-up evaluations of the patients with OSAS treated by CPAP to better evaluate their driving risk.</p>","PeriodicalId":22018,"journal":{"name":"Sleep","volume":" ","pages":""},"PeriodicalIF":5.6000,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sleep","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/sleep/zsae211","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Study objectives: To investigate the predictors of persistent driving risk related to sleepiness in patients with obstructive sleep apnea syndrome (OSAS) treated by continuous positive airway pressure (CPAP).

Methods: Longitudinal analysis of a prospective national database including 5308 patients with OSAS and an indication of CPAP. Near misses related to sleepiness, accidents related to sleepiness, and sleepiness at the wheel (SAW) were assessed before initiation and after ≥90 days of treatment. Multivariable associations with the cumulative incidence of near-misses and accidents under treatment were calculated using Cox models adjusted for age, sex, obesity, sleep duration, SAW, accidents/near-misses history, depressive symptoms, residual apnea-hypopnea index, and adherence to treatment.

Results: Residual SAW under treatment was associated with an eight-fold higher incidence of near-misses related to sleepiness (hazard ratios [HR] = 8.63 [6.08-12.2]) and five-fold higher incidence of accidents related to sleepiness (HR = 5.24 [2.81-9.78]). Adherence ≤4 h/night was also a significant predictor of persistent driving risk (HR = 1.74 [1.12-2.71] for near-misses and HR = 3.20 [1.37-7.49] for accidents).

Conclusions: Residual SAW and treatment adherence ≤4 h/night are easy-to-assess markers to detect persistent driving risk during the follow-up evaluations of patients under treatment. Health professionals, but also policymakers, should be aware of the crucial importance of systematically evaluating these elements during the follow-up evaluations of the patients with OSAS treated by CPAP to better evaluate their driving risk.

通过持续气道正压治疗的阻塞性睡眠呼吸暂停综合征患者的驾驶风险预测因素:法国多中心前瞻性队列。
研究目的调查通过持续气道正压治疗的阻塞性睡眠呼吸暂停综合征患者与嗜睡相关的持续驾驶风险的预测因素:对一个前瞻性国家数据库进行纵向分析,该数据库包括 5,308 名患有阻塞性睡眠呼吸暂停综合征并有持续气道正压治疗指征的患者。在开始治疗之前和治疗≥ 90 天之后,对与嗜睡有关的险些失误、与嗜睡有关的事故以及驾驶时的嗜睡进行了评估。使用Cox模型计算了治疗期间险些失误和事故累积发生率的多变量相关性,并对年龄、性别、肥胖、睡眠时间、嗜睡、事故/险些失误史、抑郁症状、残余呼吸暂停-低通气指数和治疗依从性进行了调整:在治疗过程中,驾驶时的残余嗜睡与嗜睡相关的险些失事发生率高出八倍(HR=8.63 [6.08-12.2])和与嗜睡相关的事故发生率高出五倍(HR=5.24 [2.81-9.78])有关。嗜睡时间≤4小时/晚也是持续驾驶风险的重要预测因素(险情发生率HR=1.74 [1.12-2.71],事故发生率HR=3.20 [1.37-7.49]):结论:在对接受治疗的患者进行随访评估时,驾驶时的残留嗜睡和治疗依从性≤4小时/晚是检测持续驾驶风险的简易评估指标。医护人员和政策制定者都应意识到,在对接受持续气道正压治疗的阻塞性睡眠呼吸暂停综合征患者进行随访评估时,系统地评估这些因素对于更好地评估其驾驶风险至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Sleep
Sleep Medicine-Neurology (clinical)
CiteScore
8.70
自引率
10.70%
发文量
0
期刊介绍: SLEEP® publishes findings from studies conducted at any level of analysis, including: Genes Molecules Cells Physiology Neural systems and circuits Behavior and cognition Self-report SLEEP® publishes articles that use a wide variety of scientific approaches and address a broad range of topics. These may include, but are not limited to: Basic and neuroscience studies of sleep and circadian mechanisms In vitro and animal models of sleep, circadian rhythms, and human disorders Pre-clinical human investigations, including the measurement and manipulation of sleep and circadian rhythms Studies in clinical or population samples. These may address factors influencing sleep and circadian rhythms (e.g., development and aging, and social and environmental influences) and relationships between sleep, circadian rhythms, health, and disease Clinical trials, epidemiology studies, implementation, and dissemination research.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信